At the J.P. Morgan Healthcare Conference, Nvidia announced major AI partnerships with Lilly and Thermo Fisher Scientific to ...

Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

A long-established drug with a diverse medical history is drawing new attention for its potential role in treating an ultra-rare and life-threatening genetic disorder. Early findings suggest that a me ...

Researchers have revealed how the popular, low-carb keto diet protects against epilepsy seizures and possibly ...

Scientists discover microgravity in space could help fight drug-resistant superbugs by creating unique viral mutations, ...

Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

Eli Lilly partnership a "monumental effort" to speed up drug creation, despite Wall Street ignoring major AI shift.

Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, molecular modeling and automated research workflows.